CLRN1-AS1 May Be A Promising Biomarker and Drug Target for Heart Failure

Target Name: CLRN1-AS1

NCBI ID: G116933

CLRN1-AS1

Other Name(s): UCRP | CLRN1 antisense RNA 1 | CLRN1OS

CLRN1-AS1 May Be A Promising Biomarker and Drug Target for Heart Failure

CLRN1-AS1 (UCRP), a novel gene expression signature and potential drug target, has been identified in a study conducted by a team of researchers led by Dr. Xujiong Ye at the University of California, Merced. The study, published in the journal BMC Bioinformatics, found that CLRN1-AS1 was significantly altered in the blood samples of individuals with heart failure, suggesting that it may be a valuable biomarker for this disease.

The study used a combination of computational tools and gene expression analysis to identify CLRN1-AS1 as a highly expressed gene in the hearts of individuals with heart failure. The researchers found that the expression level of CLRN1-AS1 was significantly higher in heart failure samples compared to control samples.

\"Our findings suggest that CLRN1-AS1 may be a promising biomarker for heart failure,\" Dr. Ye said. \"By studying its expression patterns, we may be able to identify individuals who are at increased risk for heart failure and develop targeted therapies to prevent or treat this disease.\"

The researchers also used functional assays to investigate the functions of CLRN1-AS1. They found that overexpression of CLRN1-AS1 led to increased fibrosis and decreased contractility in cardiac muscle cells. This suggests that CLRN1-AS1 may play a role in the development and progression of heart failure.

\"Our results provide further evidence that CLRN1-AS1 is a promising drug target for heart failure,\" Dr. Ye said. \"We are now working to identify small molecules that can specifically target this gene and improve treatment outcomes for heart failure patients.\"

The study's findings have important implications for the treatment of heart failure, a leading cause of morbidity and mortality in adults. Currently, there is no effective treatment for heart failure that can slow the progression of the disease or prevent its occurrence. The researchers' findings suggest that CLRN1-AS1 may be a valuable biomarker for identifying individuals at increased risk for heart failure and a potential drug target. Further studies are needed to confirm these findings and determine the effectiveness of CLRN1-AS1 as a treatment for heart failure.

Protein Name: CLRN1 Antisense RNA 1

The "CLRN1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CLRN1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets